Connor, Clark & Lunn Investment Management (CC&L)’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $6.83M | Sell |
|
|||||
|
2020
Q2 | $8.65M | Sell |
|
|||||
|
2020
Q1 | $10.5M | Sell |
|
|||||
|
2019
Q4 | $13M | Sell |
|
|||||
|
2019
Q3 | $9.48M | Sell |
|
|||||
|
2019
Q2 | $14.1M | Sell |
|
|||||
|
2019
Q1 | $18.6M | Sell |
|
|||||
|
2018
Q4 | $17.1M | Sell |
|
|||||
|
2018
Q3 | $15.7M | Buy |
|
|||||
|
2018
Q2 | $13.3M | Buy |
|
|||||
|
2018
Q1 | $14.1M | Buy |
|
|||||
|
2017
Q4 | $9.99M | Buy |
|
|||||
|
2017
Q3 | $8.86M | Buy |
|
|||||
|
2017
Q2 | $3.67M | Buy |
|
|||||
|
2017
Q1 | $3.18M | Buy |
|
|||||
|
2016
Q4 | $2.88M | Sell |
|
|||||
|
2016
Q3 | $4.67M | Sell |
|
|||||
|
2016
Q2 | $4.45M | Buy |
|
|||||
|
2016
Q1 | $4.71M | Buy |
|
|||||
|
2015
Q4 | $4.93M | Buy |
|
|||||
|
2015
Q3 | $5.41M | Buy |
|
|||||
|
2015
Q2 | $1.13M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.01M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $1.01M | Sell |
|
|||||
|
2013
Q3 | $1.85M | Sell |
|
|||||
|
2013
Q2 | $2.64M | Buy |
|